Tag: manufacturing defects

Addressing CCIT Failure During Packaging: A Step-by-Step Investigation In pharmaceutical manufacturing, the integrity of primary packaging is paramount to maintaining product quality and safety. One common issue encountered during this…

Assessing the Regulatory Risks of Container Leakage During Packaging in Pharmaceutical Manufacturing Container leakage during packaging can significantly impact pharmaceutical products, leading to compliance issues, regulatory scrutiny, and potential financial…

Investigating Glass Vial Cracks Following Supplier Changes: Ensuring CAPA Effectiveness The integrity of pharmaceutical packaging is critical, particularly in the case of sterile products housed in glass vials. An investigation…

Assessing the Regulatory Risks of Glass Vial Cracks Post Transport Simulation In pharmaceutical manufacturing, maintaining the integrity of packaging materials is crucial to ensuring product quality and compliance with regulatory…

Understanding Blister Seal Failures: A Comprehensive Approach to Investigation In the realm of pharmaceutical manufacturing, integrity in packaging is essential for maintaining product quality and compliance. A common yet critical…

Analyzing CCIT Failures During Packaging: A Comprehensive Investigation In a pharmaceutical environment, maintaining product integrity during packaging is critical. However, when Container Closure Integrity Testing (CCIT) fails, it can initiate…

Investigating Stopper Coring During Stability Testing: Packaging and Process Perspectives In the pharmaceutical manufacturing environment, deviations such as stopper coring during stability testing represent critical issues that can compromise product…

Addressing Stopper Coring Issues Following Supplier Changes In recent audits and inspections, a common yet critical issue has emerged: stopper coring observed after changes in suppliers. This phenomenon has both…

Assessing Regulatory Risks of Container Closure Mismatches During Packaging Container closure mismatches during packaging represent a critical challenge within pharmaceutical manufacturing processes, leading to potential regulatory risks and product quality…

Understanding Blister Seal Failures Following Transport Simulation: A Comprehensive Investigation Approach Blister seal failures after transport simulation pose significant challenges in pharmaceutical manufacturing, impacting product integrity and compliance. For operations…

Analyzing Glass Vial Cracks During Packaging: Effective CAPA Strategies In pharmaceutical manufacturing, the integrity of primary packaging materials such as glass vials is crucial to product quality and patient safety.…

Addressing Blister Seal Failure Following Supplier Change: An In-Depth Investigation In the realm of pharmaceutical manufacturing, ensuring the integrity of packaging is vital for product quality and compliance with regulatory…